Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
10.14
+0.25 (2.53%)
At close: Mar 9, 2026, 4:00 PM EDT
9.80
-0.34 (-3.33%)
After-hours: Mar 9, 2026, 7:44 PM EDT

Relay Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2018
Net Income
-276.48-337.71-341.97-290.51-363.87
Upgrade
Depreciation & Amortization
3.565.465.274.133.93
Upgrade
Loss (Gain) From Sale of Assets
1----
Upgrade
Asset Writedown & Restructuring Costs
2.3---123
Upgrade
Loss (Gain) From Sale of Investments
-4.95-12.42-10.761.1813.91
Upgrade
Stock-Based Compensation
62.4294.1486.0356.1448.45
Upgrade
Other Operating Activities
--13.21-6.42-11.682.84
Upgrade
Change in Accounts Receivable
--5.22-0.2877.79
Upgrade
Change in Accounts Payable
-11.4410.27-9.5911.290.93
Upgrade
Change in Unearned Revenue
-7.687.68--0.25-
Upgrade
Change in Other Net Operating Assets
-4.19-3.33-28.090.4818.62
Upgrade
Operating Cash Flow
-235.46-249.11-300.32-229.49-74.41
Upgrade
Capital Expenditures
-0.41-2.02-4.13-9.06-3.47
Upgrade
Cash Acquisitions
-----25.3
Upgrade
Investment in Securities
193.21-39.07261.76-179.68-450.74
Upgrade
Investing Cash Flow
192.8-41.08257.63-188.75-479.51
Upgrade
Issuance of Common Stock
1.6270.1534.75289.91388.09
Upgrade
Financing Cash Flow
1.6270.1534.75289.91388.09
Upgrade
Net Cash Flow
-41.05-20.04-7.93-128.33-165.83
Upgrade
Free Cash Flow
-235.87-251.13-304.44-238.55-77.88
Upgrade
Free Cash Flow Margin
-1536.08%-2509.49%-1191.74%-17273.86%-2571.05%
Upgrade
Free Cash Flow Per Share
-1.38-1.76-2.48-2.13-0.82
Upgrade
Levered Free Cash Flow
-142.71-131.63-183.52-108.6-8.17
Upgrade
Unlevered Free Cash Flow
-142.71-131.63-183.52-108.6-8.17
Upgrade
Change in Working Capital
-23.3114.62-32.4611.2597.34
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.